Natco Pharma Limited

Web: natcopharma.co.in NSE: NATCOPHARM BSE: 524816 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

829 9(-1%)

Near 52W Low of 789

Volume

2L as on 03, Sep

Open

982

High

1,406

Low

1,381

838

VWAP

841

52 Week High

1,227

52 Week Low

789

Viand Research Rating

Quality Score

2/100

Growth Score

0/100

Valuation Score

50/100

Momentum Score

0/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

14,852

No. of Shares

17.9

P/E

13.03

P/B

3.5

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

26.87

ROCE

Profit Growth

Listing Date

27-Dec-95

Promoter Holding

49.41%

FII Holding

16.99%

DII Holding

5.63%

Price Chart

Price Performance

1 Week2%

1 Month10%

3 Months10%

6 Months12%

1 Year2%

YTD6%

Moving Average

5 Day SMA845

10 Day SMA858

20 Day SMA882

30 Day SMA896

50 Day SMA917

61 Day SMA908

80 Day SMA946

200 Day SMA945

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	880	850	869	879
Resistance 2	869	848	859	868
Resistance 1	856	845	854	855
Pivot Point	845	843	845	844
Support 1	832	841	836	831
Support 2	821	839	830	821
Support 3	808	837	821	808

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 49.41%	(-0.11) 49.41%	(0.01) 49.48%	(-0.11) 49.48%	(0.01) 49.56%	(-0.11) 49.56%	(0.01) 49.62%	(-0.11) 49.62%	(0.01) 49.71%	(0.01) 49.71%	(0.01) 49.71%	(0.01) 49.71%	(0.91) 49.76%	(0.01) 48.84%	(0.01) 48.82%	(0.01) 48.80%	(0.01) 48.80%	(0.01) 48.81%	(0.01) 48.86%	(0.01) 48.87%
FIIs	(-0.41) 16.99%	(2.21) 17.37%	(1.11) 15.16%	(-1.41) 14.09%	(-2.01) 15.52%	(-0.51) 17.49%	(0.41) 17.94%	(0.11) 17.51%	(1.31) 17.45%	(2.41) 16.14%	(0.91) 13.72%	(1.81) 12.82%	(-0.91) 11.03%	(0.21) 11.91%	(0.11) 11.73%	(0.01) 11.67%	(-0.31) 11.65%	(-0.31) 11.94%	(-0.31) 12.26%	(0.01) 12.53%
DIIs	(0.21) 5.63%	(0.11) 5.46%	(-0.51) 5.39%	(0.11) 5.87%	(0.21) 5.81%	(0.01) 5.64%	(-1.21) 5.59%	(-1.11) 6.75%	(-1.81) 7.86%	(-1.61) 9.69%	(-2.81) 11.26%	(-1.11) 14.01%	(-0.21) 15.15%	(0.51) 15.38%	(0.61) 14.93%	(-1.01) 14.30%	(-0.81) 15.30%	(-1.91) 16.15%	(0.31) 18.08%	(0.01) 17.78%
Public	27.97%	27.74%	29.97%	30.56%	29.12%	27.30%	26.88%	26.13%	24.99%	24.46%	25.32%	23.48%	24.08%	23.87%	24.53%	25.23%	24.25%	23.10%	20.80%	20.82%
No. of Shareholders	403,166	410,970	424,167	419,699	429,434	405,222	345,332	302,944	251,485	228,467	207,571	163,753	155,181	153,663	135,397	121,336	92,449	85,828	88,421	88,439

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	735	739	647	1363	1329	1221	475	1371	1363	1068	759	1031	1140	898	492	432	885	597	560	377	410
Sales Growth % (YoY)	-44.7%	-39.5%	36.3%	-0.6%	-2.5%	14.3%	-37.4%	32.9%	19.5%	19%	54%	138.7%	28.9%	50.4%	-12.1%	14.6%	115.6%	80.1%	57.8%	-53%	-27.2%
Sales Growth % (QoQ)	-0.5%	14.2%	-52.5%	2.6%	8.8%	157.1%	-65.4%	0.6%	27.6%	40.7%	-26.4%	-9.6%	26.9%	82.5%	13.9%	-51.2%	48.2%	6.6%	48.5%	-8%	-
Expenses	549	612	489	784	758	673	436	567	558	571	490	573	612	559	387	337	489	615	459	307	300
Operating Profit	186	128	159	579	571	548	39	804	805	497	268	458	528	339	106	95	395	-19	102	70	110
OPM %	25	17	25	42	43	45	8	59	59	47	35	44	46	38	22	22	45	-3	18	19	27
Other Income	59	78	58	100	62	66	176	64	48	42	37	29	20	29	21	20	34	14	30	38	17
Interest	13	11	10	13	3	10	4	4	5	6	5	4	4	3	4	4	4	7	5	4	2
Depreciation	47	50	46	52	58	98	47	46	44	56	44	44	44	41	42	42	40	38	36	35	34
Profit before tax	186	144	161	614	572	506	164	818	804	478	256	440	500	324	81	70	386	-50	91	70	91
Tax %	34	-62	13	16	16	20	19	17	17	19	17	16	16	15	23	19	17	2	12	7	18
Net Profit	206	269	151	518	480	406	132	676	668	386	213	369	420	276	62	57	320	-50	80	65	75
Net Profit Growth % (QoQ)	-23.4%	78.1%	-70.8%	7.9%	18.2%	207.6%	-80.5%	1.2%	73.1%	81.2%	-42.3%	-12.1%	52.2%	345.2%	8.8%	-82.2%	740%	-162.5%	23.1%	-13.3%	-
Net Profit Growth % (YoY)	-57.1%	-33.7%	14.4%	-23.4%	-28.1%	5.2%	-38%	83.2%	59%	39.9%	243.5%	547.4%	31.2%	652%	-22.5%	-12.3%	326.7%	-	-	-	-
TTM Net Profit	1144	1418	1555	1536	1694	1882	1862	1943	1636	1388	1278	1127	815	715	389	407	415	170	220	140	0
EPS in Rs	11.53	14.96	8.46	28.94	26.84	22.7	7.43	37.81	37.32	21.57	11.88	20.6	23.47	15.11	3.41	3.11	17.55	-2.77	4.41	3.57	4.11

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	4078	4430	3999	2707	1945	2052	1915	2094	2185	2020	1042	825	739	661
Sales Growth %	-7.9%	10.8%	47.7%	39.2%	-5.2%	7.2%	-8.6%	-4.1%	8.2%	93.8%	26.3%	11.7%	11.9%	26.1%
Expenses	2642	2234	2245	1772	1681	1446	1332	1300	1256	1337	777	615	560	511
Operating Profit	1436	2196	1754	936	264	606	583	795	928	683	266	210	179	150
OPM %	35	50	44	35	14	30	30	38	42	34	25	25	24	23
Other Income	298	354	126	105	99	104	107	130	40	14	12	0	17	1
Interest	37	24	19	14	18	13	22	19	15	18	23	32	37	26
Depreciation	207	235	187	164	143	117	100	81	66	54	51	47	30	22
Profit before tax	1491	2291	1674	862	202	580	569	825	887	624	204	132	129	102
Tax %	8	18	17	17	16	24	19	22	22	22	24	1	24	36
Net Profit	1418	1883	1388	715	170	442	458	642	695	485	156	130	98	66
Net Profit Growth %	-24.7%	35.7%	94.1%	320.6%	-61.5%	-3.5%	-28.7%	-7.6%	43.3%	210.9%	20%	32.7%	48.5%	-
EPS in Rs	79.2	105.26	77.51	39.18	9.31	24.18	25.31	35.24	37.74	27.88	9.02	8.1	6.21	4.58
Dividend Payout %	6	6	12	14	48	22	27	18	22	24	14	12	16	17

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	1768	1697	1212	849	46	299	417	669	464	346	112	93	144	61
Cash from Investing Activity	-2082	-1436	-1026	-465	4	-107	-175	-611	-1116	-299	-176	-120	-108	-111
Cash from Financing Activity	298	-211	-247	-363	35	-186	-251	-51	651	-48	154	29	-35	26
Net Cash Flow	-16	50	-62	21	85	6	-8	7	-2	-1	90	2	0	-24

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	36	36	36	36	36	36	36	36	36	36	37	35	35	33	33	31
Reserves	9185	8614	7571	7114	5817	4837	4227	4085	3737	3452	3035	1614	1261	813	693	502
Borrowings	714	261	279	208	371	167	416	268	316	386	173	222	113	312	240	338
Other Liabilities	1139	1520	744	886	682	617	430	403	498	428	470	446	413	226	229	209
Total Liabilities	11074	10430	8631	8245	6906	5657	5109	4792	4588	4303	3715	2318	1822	1384	1196	1080
Fixed Assets	2803	2697	2698	2541	2491	2427	2312	2023	1584	1227	1019	833	710	710	645	583
CWIP	294	255	225	234	137	64	130	223	518	638	480	336	212	129	124	106
Investments	3127	774	474	643	539	392	308	304	112	169	76	32	22	2	2	2
Other Assets	4850	6704	5234	4826	3739	2774	2360	2242	2373	2270	2140	1116	878	543	425	389
Total Assets	11074	10430	8631	8245	6906	5657	5109	4792	4588	4303	3715	2318	1822	1384	1196	1080

Delivery

Delivery Data: NATCOPHARM

#	Date	826 21% 997	Value (Cr)	Q/T 20	Del 42	Del 37
1	4-Sep	829	37	13	60	22
2	3-Sep	838	18	9	53	10
3	2-Sep	843	40	12	53	21
4	1-Sep	849	20	10	54	11
5	31-Aug	842	35	11	61	21
6	28-Aug	854	34	13	57	20
7	27-Aug	858	24	11	50	12
8	26-Aug	863	32	15	47	15
9	25-Aug	866	39	12	60	23
10	24-Aug	884	28	13	41	11
11	21-Aug	882	32	15	35	11
12	20-Aug	878	24	15	49	12
13	19-Aug	887	29	11	44	13
14	18-Aug	898	25	13	42	11
15	17-Aug	890	75	17	38	29
16	14-Aug	903	227	24	17	39
17	13-Aug	952	114	21	37	42
18	12-Aug	915	25	15	53	13
19	11-Aug	907	37	15	41	15
20	10-Aug	910	18	13	48	9
21	7-Aug	917	15	12	48	7
22	6-Aug	912	19	11	48	9
23	5-Aug	918	22	13	43	9
24	4-Aug	917	29	13	53	15
25	3-Aug	929	27	13	53	14
26	31-Jul	917	30	15	68	21
27	30-Jul	930	22	14	47	10
28	29-Jul	936	16	15	50	8
29	28-Jul	925	14	11	53	7
30	27-Jul	927	21	13	54	12
31	24-Jul	921	19	14	46	9
32	23-Jul	919	26	13	44	12
33	22-Jul	934	38	13	44	17
34	21-Jul	962	30	17	39	12
35	20-Jul	951	95	21	21	20
36	17-Jul	945	32	15	53	17
37	16-Jul	966	32	13	43	14
38	15-Jul	970	26	17	48	12
39	14-Jul	972	29	16	46	13
40	13-Jul	980	56	16	42	24
41	10-Jul	984	69	19	39	27
42	9-Jul	962	43	17	40	17
43	8-Jul	966	103	19	35	36
44	7-Jul	984	227	30	29	66
45	6-Jul	932	25	17	42	11
46	3-Jul	931	20	13	48	10
47	2-Jul	934	38	16	48	18
48	1-Jul	926	54	22	47	25
49	30-Jun	931	59	22	56	33
50	29-Jun	920	107	21	44	47

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	14,852c	160c	1.07
03-Sep	15,012c	107c	0.70
01-Sep	15,119c	112c	0.73
31-Aug	15,231c	92c	0.60
27-Aug	15,323c	261c	1.67
26-Aug	15,584c	56c	0.36
25-Aug	15,528c	252c	1.59
24-Aug	15,780c	281c	1.75
21-Aug	16,061c	210c	1.32
19-Aug	15,851c	269c	1.67
18-Aug	16,120c	108c	0.67
17-Aug	16,012c	233c	1.43
14-Aug	16,245c	722c	4.25
13-Aug	16,967c	543c	3.30
12-Aug	16,424c	20c	0.12
11-Aug	16,444c	64c	0.39
10-Aug	16,508c	151c	0.92
06-Aug	16,357c	52c	0.32
04-Aug	16,409c	60c	0.36
31-Jul	16,469c	293c	1.75
30-Jul	16,762c	29c	0.17
29-Jul	16,733c	112c	0.67
28-Jul	16,621c	25c	0.15
27-Jul	16,596c	29c	0.17
24-Jul	16,568c	0	0

Stock Checklist

Price is above from 52 week high low average: 9%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: NO

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 104 fund scheme(s) across 24 fund house(s) as of Aug26 · Total value ₹573 Cr · 14 increasing / 48 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Tata Mutual Fund	8	0.60%	-0.15%	258.2
Sundaram Mutual Fund	2	1.44%	-0.32%	113
Bandhan Mutual Fund	8	0.60%	+0.35%	38.3
Nippon India Mutual Fund	6	0.36%	-0.11%	28.8
Samco Mutual Fund	8	1.21%	-	25.5
Axis Mutual Fund	6	0.75%	-0.37%	16.9
SBI Mutual Fund	4	0.28%	-0.11%	13.8
Motilal Oswal Mutual Fund	8	0.15%	-0.12%	13.3
DSP Mutual Fund	6	1.50%	+1.60%	10.3
The Wealth Company Mutual Fund	2	1.81%	-0.11%	8.7
Edelweiss Mutual Fund	4	0.43%	+0.29%	7.4
Aditya Birla Sun Life Mutual Fund	2	1.03%	-0.32%	7.2
HDFC Mutual Fund	6	0.22%	-0.01%	6.8
ICICI Prudential Mutual Fund	4	0.34%	-0.01%	5.8
Jio BlackRock Mutual Fund	3	0.14%	-0.49%	5.5
Kotak Mahindra Mutual Fund	4	0.88%	-0.06%	5.2
Franklin Templeton Mutual Fund	2	0.37%	-0.02%	4.5
Groww Mutual Fund	4	0.13%	-0.09%	1.3
Navi Mutual Fund	6	0.53%	+0.01%	0.8
UTI Mutual Fund	2	0.30%	+0.30%	0.8
LIC Mutual Fund	2	0.68%	+0.55%	0.4
Angel One Mutual Fund	4	0.17%	+0.36%	0.3
Mirae Asset Mutual Fund	2	0.04%	-0.01%	0
Zerodha Mutual Fund	1	0.20%	-	0

Natco Pharma Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements